| Subject | Predicate | Object |
|---|---|---|
| What consideration the Medicines Control Agency is giving to licensing the process made available to the Scottish National Blood Transfusion Service to produce a higher potency Factor VIII for the rest of the commercial plasma fractionation/supply industry in the United Kingdom. | ||
| http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_174025 | ||